The agency is still working on the authorization, said the officials, who spoke on the condition of anonymity to speak freely. Shortly after the FDA decision, a Centers for Disease Control and Prevention advisory committee is expected to meet to recommend how the vaccine should be used.
Support Our News Campaign
Shop our StoreClick Here To Shop
Subscribe to the newsletter news
We hate SPAM and promise to keep your email address safe